New bird flu vaccine could tackle multiple variants with one shot
Nature Podcast
[email protected]
4.4 • 859 Ratings
🗓️ 15 October 2025
⏱️ 25 minutes
🧾️ Download transcript
Summary
00:46 A multi-variant avian flu vaccine that could enhance pandemic preparedness
A vaccine capable of protecting against multiple strains of avian influenza virus may be a step closer, according to new research. The H5 subtype of avian influenza viruses has spilled over into mammals and is particularly concerning to researchers due to the risk of them evolving to cause another pandemic. But because there are multiple variants of these viruses, it has been hard to pre-prepare vaccines. Now, a team have used information on how these viruses evolved over time to design a vaccine that in animal studies provided protection against different H5 strains. They hope their approach could be applied to create stockpiles of vaccine that could be used in the event of a pandemic, regardless of the strain that causes it.
Research Article: Kok et al.
10:53 Research Highlights
Making muon beams without a huge particle accelerator — plus, the bats hunting migrating birds in mid-air.
Research Highlight: Portable muon beam could accelerate archaeology scans
Research Highlight: European bats capture migrating birds and eat them on the wing
13:34 Briefing Chat
A new search engine that can sift through the staggering volumes of biological data, and the multiple failings revealed by an assessment of 25 years of carbon offsetting data.
Nature: ‘Google for DNA’ brings order to biology’s big data
The Guardian: Carbon offsets fail to cut global heating due to ‘intractable’ systemic problems, study says
Hosted on Acast. See acast.com/privacy for more information.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | This moment, Alex's mile swim, it means everything to him and to all of us. |
| 0:05.2 | At Ever North's specialty services, we help providers make sure patient care doesn't get interrupted, |
| 0:10.1 | especially for rare, chronic, and complex conditions. |
| 0:13.3 | Now Alex and his care team have his hemophilia under control with life-saving medication and care management |
| 0:18.2 | from Ever North's specialty pharmacy, Accredo. |
| 0:21.0 | So Alex can be the last one out of the pool. |
| 0:23.8 | Evernorth's specialty services, because every moment counts. |
| 0:27.0 | Visit evernorth.com slash specialty to learn more. |
| 0:30.3 | Hello, everyone. It's Jamie Lang here from Great Company podcast, |
| 0:33.6 | and I want to let you know that my podcast is currently being sponsored by Premier Inn. |
| 0:37.6 | Now, this episode is sponsored by Premier in, the UK's largest hotel chain with over 800 hotels across the country. |
| 0:44.0 | So wherever work takes you, there's a Premier Inn nearby. |
| 0:47.2 | Now, every room has a super comfy bed. I've stayed in there, incredible, and blackout curtains, |
| 0:51.3 | so you'll wake up refreshed and ready for the day ahead. And don't forget the unlimited breakfast to fuel your mornings. So for your next work trip, |
| 0:58.6 | get better sleep for your money at Premier Inn. Book now at premier in.com. |
| 1:04.8 | Nature and experiment. We don't know yet. Why is it like so far like it sounds so simple they had no idea |
| 1:15.5 | but now the data's i find this not only refreshing but but at some level astounding nature |
| 1:28.3 | welcome back to the Nature podcast. |
| 1:30.8 | This week, designing a flu vaccine that gives broad immunity... |
| 1:34.8 | And reviewing 25 years of carbon offsets. |
| 1:38.3 | I'm Charmany Bondell. |
| 1:39.4 | And I'm Benjamin Thompson. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from [email protected], and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of [email protected] and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.